A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties (Q39177528)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on 18 March 2013
Language Label Description Also known as
English
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties
scientific article published on 18 March 2013

    Statements

    title
    A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    23518155
    retrieved
    9 September 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q39177528&oldid=2197556139"